We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Sandoz has asked a federal court for a summary judgment to force the FDA to make a decision on its application to market the follow-on human growth hormone Omnitrope.